参考文献/References:
[1]Hilfiker-Kleiner D,Hilfiker A,Fuchs M,et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth,control of interstitial matrix deposition ,and heart protection from ischemic injury[J]. Circ Res 95(2):187-195.
[2]Kurdi M,Booz GW. JAK redux :a second look at the regulation and role of JAKs in the heart[J]. Am J Physiol Heart Circ Physiol,2009,297(5):H1545-H1556.
[3] Benussi S,de Maat GE. Atrial remodelling and function:implications for atrial fibrillation surgery[J]. Eur J Cardiothorac Surg,2018,53(suppl_1):i2-i8.
[4] Lau DH,Schotten U,Mahajan R,et al. Novel mechanisms in the pathogenesis of atrial fibrillation:practical applications[J]. Eur Heart J,2016,37(20):1573-1581.
[5]Bharadwaj U ,Kasembeli MM,Eckols TK,et al. Monoclonal antibodies specific for STAT3beta reveal its contribution to constitutive STAT3 phosphorylation in breast cancer[J]. Cancers (Basel),2014,6(4):2012-2034.
[6] Haghikia A,Ricke-Hoch M,Stapel B,et al. STAT3,a key regulator of cell-to-cell communication in the heart[J]. Cardiovasc Res,2014,102(2):281-289.
[7] Nattel S,Burstein B,Dobrev D. Atrial remodeling and atrial fibrillation:mechanisms and implications[J]. Circ Arrhythm Electrophysiol,2008,1(1):62-73.
[8] Andrade J,Khairy P,Dobrev D,et al. The clinical profile and pathophysiology of atrial fibrillation:relationships among clinical features,epidemiology,and mechanisms[J]. Circ Res,2014,114(9):1453-1468.
[9] Tan AY,Zimetbaum P. Atrial fibrillation and atrial fibrosis[J]. J Cardiovasc Pharmacol,2011,57(6):625-629.
[10] Venteclef N,Guglielmi V,Balse E,et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines[J]. Eur Heart J,2015,36(13):795-805.
[11] Haghikia A,Stapel B,Hoch M,et al. STAT3 and cardiac remodeling[J]. Heart Fail Rev,2011,16(1):35-47.
[12] Li D,Shinagawa K,Pang L,et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure[J]. Circulation,2001,104(21):2608-2614.
[13] Savelieva I,John CA. Atrial fibrillation and heart failure:natural history and pharmacological treatment[J]. Europace,2004,5 Suppl 1:S5-S19.
[14] Faruqi TR,Gomez D,Bustelo XR,et al. Rac1 mediates STAT3 activation by autocrine IL-6[J]. Proc Natl Acad Sci U S A,2001,98(16):9014-9019.
[15] Misao J,Hayakawa Y,Ohno M,et al. Expression of bcl-2 protein,an inhibitor of apoptosis,and Bax,an accelerator of apoptosis,in ventricular myocytes of human hearts with myocardial infarction[J]. Circulation,1996,94(7):1506-1512.
[16] Tsai CT,Lai LP,Kuo KT,et al. AngiotensinⅡactivates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts:implication for the therapeutic effect of statin in atrial structural remodeling[J]. Circulation,2008,117(3):344-355.
[17] Tsai CT,Lin JL,Lai LP,et al. Membrane translocation of small GTPase Rac1 and activation of STAT1 and STAT3 in pacing-induced sustained atrial fibrillation[J]. Heart Rhythm,2008,5(9):1285-1293.
[18] Xue XD,Huang JH,Wang HS. AngiotensinⅡactivates signal transducers and activators of transcription 3 via Rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease[J]. Cell Biochem Biophys,2015,71(1):205-213.
[19] Zheng LY,Zhang MH,Xue J H,et al. Effect of angiotensinⅡon STAT3 mediated atrial structural remodeling[J]. Eur Rev Med Pharmacol Sci,2014,18(16):2365-2377.
[20] Zheng L,Jia X,Zhang C,et al. AngiotensinⅡin atrial structural remodeling:the role of AngⅡ/JAK/STAT3 signaling pathway[J]. Am J Transl Res,2015,7(6):1021-1031.
[21] Huang Z,Chen XJ,Qian C,et al. Signal transducer and activator of transcription 3/microRNA-21 feedback loop contributes to atrial fibrillation by promoting atrial fibrosis in a rat sterile pericarditis model[J]. Circ Arrhythm Electrophysiol,2016,9(7), pii: e003396.
[22] Cao W,Shi P,Ge JJ. miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway[J]. BMC Cardiovasc Disord,2017,17(1):88.
[23] Hu YF,Chen YJ,Lin YJ,et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol,2015,12(4):230-243.
[24] Mir SA,Chatterjee A,Mitra A,et al. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6(IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart[J]. J Biol Chem,2012,287(4):2666-2677.
[25]Hao L,Ren M,Rong B,et al. TWEAK/Fn14 mediates atrial-derived HL-1 myocytes hypertrophy via JAK2/STAT3 signalling pathway[J]. J Cell Mol Med,2018,22(9):4344-4353.
[26]Jiang Q,Ni B,Shi J,et al. Down-regulation of ATBF1 activates STAT3 signaling via PIAS3 in pacing-induced HL-1 atrial myocytes[J]. Biochem Biophys Res Commun,2014,449(3):278-283.
[27] Krishnamurthy P,Rajasingh J,Lambers E,et al. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR[J]. Circ Res,2009,104(2):e9-e18.
[28] Obana M,Maeda M,Takeda K,et al. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction[J]. Circulation,2010,121(5):684-691.
[29] Dong Q,Li S,Wang W,et al. FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways[J]. J Cell Physiol,2019,234(11):19502-19510.
[30] Chen Y,Surinkaew S,Naud P,et al. JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate[J]. Cardiovasc Res,2017,113(3):310-320.
[31] Chang SH,Yeh YH,Lee JL,et al. Transforming growth factor-beta-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation[J]. Basic Res Cardiol,2017,112(5):58.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(1):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(1):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(1):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]